Evidence map›Paper›PMID 29850024›Full record

ArticlePharmacology research & perspectives2018

Expression of cytochrome P450 mRNAs in Type II alveolar cells from subjects with chronic obstructive pulmonary disease.

Satoshi Kamata, Naoya Fujino, Mitsuhiro Yamada, Ken Grime, Satoshi Suzuki, Chiharu Ota, Yukiko Tando, Yoshinori Okada, Akira Sakurada, Masafumi Noda and 3 more

Open access · goldAbstract read
In one paragraph

Article in Pharmacology research & perspectives, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 13 papers.

0numbers the graph read from it
0cells of the map it votes in
13citing papers in PubMed
3.0field-weighted citation impact, top 10% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

13 citing papers in PubMed, 25 citations in OpenAlex.

  1. The intersection of liver cirrhosis and pulmonary fibrosis.Journal of translational medicine · 2025
    Review
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Review
  9. Article
  10. Article
  11. International journal of chronic obstructive pulmonary disease · 2020
    Article
  12. Upregulation of Chitinase 1 in Alveolar Macrophages of HIV-Infected Smokers.Journal of immunology (Baltimore, Md. : 1950) · 2019
    Article
  13. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors at 2 institutions in 2 countries.

Satoshi KamataDepartment of Thoracic Surgery Institute of Development, Aging and Cancer Tohoku University Sendai Japan.
Naoya FujinoDepartment of Respiratory Medicine Tohoku University Graduate School of Medicine Sendai Japan.ORCID 0000-0003-3174-2632
Mitsuhiro YamadaDepartment of Respiratory Medicine Tohoku University Graduate School of Medicine Sendai Japan.
Ken GrimeRespiratory Inflammation & Autoimmunity IMED Biotech Unit AstraZeneca Gothenburg Sweden.
Satoshi SuzukiDepartment of Thoracic Surgery Japanese Red Cross Ishinomaki Hospital Ishinomaki Japan.
Chiharu OtaDepartment of Advanced Preventive Medicine for Infectious Disease Tohoku University Graduate School of Medicine Sendai Japan.
Yukiko TandoDepartment of Advanced Preventive Medicine for Infectious Disease Tohoku University Graduate School of Medicine Sendai Japan.
Yoshinori OkadaDepartment of Thoracic Surgery Institute of Development, Aging and Cancer Tohoku University Sendai Japan.
Akira SakuradaDepartment of Thoracic Surgery Institute of Development, Aging and Cancer Tohoku University Sendai Japan.
Masafumi NodaDepartment of Thoracic Surgery Institute of Development, Aging and Cancer Tohoku University Sendai Japan.
Yasushi MatsudaDepartment of Thoracic Surgery Institute of Development, Aging and Cancer Tohoku University Sendai Japan.
Hisatoshi SugiuraDepartment of Respiratory Medicine Tohoku University Graduate School of Medicine Sendai Japan.
Masakazu IchinoseDepartment of Respiratory Medicine Tohoku University Graduate School of Medicine Sendai Japan.
Tohoku University · JPAstraZeneca (Sweden) · SE

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Inhaled drugs are critical for the treatment of inflammatory airway diseases such as chronic obstructive pulmonary disease (COPD). To develop better therapeutics for pulmonary disease it is of potential importance to understand molecular mechanisms of local biotransformation in the lung. Alveolar epithelial type II (ATII) cells have a key role in homeostasis in the lung, but little is known about expression patterns of genes encoding cytochrome P450 (CYP) enzymes in ATII cells. In addition, alteration of CYP gene expression has not been fully defined in COPD. We previously established a method to purify ATII cells from the adult human lung using fluorescence-activated cell sorting. By employing this technique we determined gene expression patterns of 14 CYP enzymes in ATII cells from nonsmokers (n = 4) and smokers (n = 4), both having normal pulmonary function. Although most CYP genes are highly expressed in primary hepatocytes, we found that

Indexed as

Up-RegulationAgedAged, 80 and overAlveolar Epithelial CellsCytochrome P-450 CYP1B1Cytochrome P-450 CYP2C19Cytochrome P-450 CYP2J2Cytochrome P-450 Enzyme SystemFemaleHepatocytesHumansMaleMiddle AgedPulmonary Disease, Chronic ObstructiveSmokingCYP1B1 protein, humanCYP2C19 protein, humanCYP2J2 protein, humanCytochrome P-450 CYP1B1Cytochrome P-450 CYP2C19Cytochrome P-450 CYP2J2Cytochrome P-450 Enzyme Systemalveolar epithelial type II cellschronic obstructive pulmonary diseasecytochrome P450 enzymeslung

Identifiers

PMID29850024
PMCPMC5964255
OpenAlexW2803690555

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.